™Your Policy Risk Impact Agent
53 chapters · 983 sections in this title.
O.C.G.A. § 31-52-1 Short title
0.2K chars
This chapter shall be known and may be cited as the ‘‘Georgia Right to Try Act.’’ History. — Code 1981, § 31-52-1, enacted by Ga. L. 2016, p. 345, § 1/HB 34.
O.C.G.A. § 31-52-10 Statutory construction
1.5K chars
(a) This chapter shall not be construed to create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person or entity involved in the care of an eligible patient using an investigational drug, biological…
O.C.G.A. § 31-52-2 Legislative findings
1.4K chars
(a) The General Assembly finds and declares that: (1) The process of approval for investigational drugs, biological products, and devices in the United States protects future patients from premature, ineffective, and unsafe medications and treatments over the long run, but the pr…
O.C.G.A. § 31-52-3 Definitions
1.4K chars
As used in this chapter, the term: (1) ‘‘Eligible patient’’ means a person who meets the requirements of Code Section 31-52-4. (2) ‘‘Investigational drug, biological product, or device’’ means a drug, biological product, or device which has successfully completed Phase I of a fed…